DAGGER
Live / Registered — Registered (as of 05 Sept 2023)
What this means for you
Registered since 05 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97688353
- Registration number
- 7159383
- Mark type
- Stylized text
- Filed
- 22 Nov 2022
- Published for opposition
- 07 Feb 2023
- Registered
- 05 Sept 2023
- Attorney of record
- Colleen Ganin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy; pharmaceutical and biological preparations for immunotherapy, namely, for use in improving immune evasion, improving cell expansion and potency, and/or reducing rejection by patient immune system
Owner
- Allogene Therapeutics, Inc., South San Francisco, CA, US
- Allogene Therapeutics, Inc., South San Francisco, CA, US
- Allogene Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 28 Feb 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 28 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 04 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Aug 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Aug 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Jul 2023 — USE AMENDMENT FILED
- 03 Aug 2023 — SOU EXTENSION 1 GRANTED
- 24 Jul 2023 — SOU EXTENSION 1 FILED
- 01 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jul 2023 — SOU TEAS EXTENSION RECEIVED